Vitamin C (anti-inflammatory) supplementation could attenuate the degeneration of the albino rat thyroid gland induced by oral monosodium glutamate and kill thyroid cancer cells by inhibiting MAPK/ERK and PI3K/AKT pathways via a ROS-dependent mechanism [58,59]. This evidence concerns the gene AKT1 and thyroid gland carcinoma.